BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10450731)

  • 1. Protein markers in colorectal cancer: predictors of liver metastasis.
    Berney CR; Fisher RJ; Yang J; Russell PJ; Crowe PJ
    Ann Surg; 1999 Aug; 230(2):179-84. PubMed ID: 10450731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression.
    Berney CR; Yang J; Fisher RJ; Russell PJ; Crowe PJ
    Oncol Res; 1998; 10(1):47-54. PubMed ID: 9613457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive value of vascular endothelial growth factor and nm23 for the diagnosis of occult metastasis in non-small cell lung cancer.
    Ohta Y; Nozaki Z; Nozawa H; Kamesui T; Tsunezuka Y; Oda M; Watanabe G
    Jpn J Cancer Res; 2001 Mar; 92(3):361-6. PubMed ID: 11267948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
    Lee KE; Lee HJ; Kim YH; Yu HJ; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
    Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer.
    Ohta Y; Nozawa H; Tanaka Y; Oda M; Watanabe Y
    J Thorac Cardiovasc Surg; 2000 Apr; 119(4 Pt 1):804-13. PubMed ID: 10733773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of nm23 protein assessed by color video image analysis in metastatic colorectal cancer: correlation with reduced patient survival.
    Berney CR; Yang JL; Fisher RJ; Russell PJ; Crowe PJ
    World J Surg; 1998 May; 22(5):484-90. PubMed ID: 9564293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase receptor and vascular endothelial growth factor are synergistically associated with the liver metastasis of colorectal cancer.
    Konno H; Abe J; Kaneko T; Baba M; Shoji A; Sunayama K; Kamiya K; Tanaka T; Suzuki S; Nakamura S; Urano T
    Jpn J Cancer Res; 2001 May; 92(5):516-23. PubMed ID: 11376560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
    Sarris M; Lee CS
    Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive relationship between expression of CD44 and hepatic metastases in colorectal cancer.
    Ichikawa W
    Pathobiology; 1994; 62(4):172-9. PubMed ID: 7537507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53, c-erbB-2 and nm23 expression have no prognostic significance in primary pulmonary adenocarcinoma.
    MacKinnon M; Kerr KM; King G; Kennedy MM; Cockburn JS; Jeffrey RR
    Eur J Cardiothorac Surg; 1997 May; 11(5):838-42. PubMed ID: 9196297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas.
    Cheah PY; Cao X; Eu KW; Seow-Choen F
    Br J Cancer; 1998 Apr; 77(7):1164-8. PubMed ID: 9569056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers.
    Nakata S; Ito K; Fujimori M; Shingu K; Kajikawa S; Adachi W; Matsuyama I; Tsuchiya S; Kuwano M; Amano J
    Int J Cancer; 1998 Apr; 79(2):179-86. PubMed ID: 9583734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on C-erbB2, nm23 and p53 expressions in epithelial ovarian cancer and their clinical significance].
    Liu L; Yang K
    Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):101-4. PubMed ID: 11263193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.
    Tian J; Tang ZY; Ye SL; Liu YK; Lin ZY; Chen J; Xue Q
    Br J Cancer; 1999 Nov; 81(5):814-21. PubMed ID: 10555751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor expression is reduced in liver metastasis from colorectal cancer and correlates with urokinase-type plasminogen activator.
    Berney CR; Yang JL; Fisher RJ; Russell PJ; Crowe PJ
    Anticancer Res; 1998; 18(2A):973-7. PubMed ID: 9615749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
    Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
    Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical study of p53, c-erbB-2 and nm23 proteins in human gastric cancer].
    Wei Z; Wu Y; Zhai Z
    Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):378-81. PubMed ID: 10920922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis.
    Kang SM; Maeda K; Onoda N; Chung YS; Nakata B; Nishiguchi Y; Sowa M
    Int J Cancer; 1997 Oct; 74(5):502-7. PubMed ID: 9355971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.